The EMA human medicines committee (CHMP) has recently issued a statement on Obeticholic acid for the treatment of Primary Biliary Cholangitis (PBC). The CHMP recommended to the European Commission that the market authorisation for Obeticholic acid in the European Union…
• First patient enrolled at Hôpital Beaujon, Clichy, France • The COMBAT Trial is a multicenter, randomized, open-label, Phase II clinical trial in patients with decompensated cirrhosis Barcelona, Spain, 9th July 2024 – DECISION, an EU-funded research consortium in liver…
The European Association for the Study of the Liver (EASL)is delighted to announce that JHEP Reports, its Open Access publication, achieved an impressive impact factor of 9.5 in the 2024 release of Journal Citation Reports (JCR) by Clarivate. This notable…
The European Association for the Study of the Liver (EASL) is proud to announce that the Journal of Hepatology, its flagship publication, achieved an impact factor of 26.8 in the 2024 release of Journal Citation Reports (JCR) by Clarivate, solidifying…
The European Association for the Study of the Liver (EASL) is proud to announce the appointment of Prof. Vlad Ratziu as the new Editor-in-Chief of the Journal of Hepatology, the premier publication in the field of liver research. This prestigious…
Introducing the EASL Guidelines App – your indispensable mobile companion for accessing comprehensive and up-to-date clinical practice guidelines in hepatology. Developed by EASL, the European Association for the Study of the Liver, this app is meticulously designed to support healthcare…
The GENIAL project is dedicated to enhancing our understanding of the early stages of alcohol-related hepatocellular carcinoma (ALD-HCC) by integrating clinical hepatology expertise with artificial intelligence (AI). This innovative initiative, as explained by project coordinator Eric Trépo, aims to significantly…
Liver diseases pose a significant global health challenge, with conditions like liver fibrosis often remaining undetected until they reach advanced stages, leading to severe consequences such as cirrhosis and liver cancer. In response to this pressing issue, the LIVERSCREEN project…
Amsterdam, May 2, 2024 – New evidence reveals global underassessment and undertreatment of chronic hepatitis B (HBV), especially among women and Asian minorities in the West, a new study in the Journal of Hepatology, published by Elsevier, details. "In clinical practice…
The liver community mourns the loss of Dr. Stephen Harrison, a visionary in MASLD clinics and clinical research, whose contributions have shaped the current state of the field. Dr. Stephen Harrison was an early clinical researcher who dedicated his career…